Real-world treatment utilization and effectiveness of onabotulinumtoxinA in multiple sclerosis patients treated for spasticity from the ASPIRE study

被引：0
|
作者：
Bandari, D. S. [1 ,2 ]
Mayadev, A. [3 ]
Sakel, M. [4 ]
Esquenazi, A. [5 ]
Zuzek, A. [6 ]
Largent, J. [7 ]
Francisco, G. E. [8 ,9 ]
机构：
[1] Hoag Neurosci Inst, Multiple Sclerosis Ctr Calif, Newport Beach, CA USA
[2] Hoag Neurosci Inst, Res Grp, Newport Beach, CA USA
[3] Swedish Neurosci Inst, Multiple Sclerosis Ctr Rehabil Program, Seattle, WA USA
[4] Kent & Canterbury Hosp, East Kent Hosp Univ NHS Fdn, Caterbury, England
[5] MossRehab Gait & Mot Anal Lab, Elkins Pk, PA USA
[6] Allergan Plc, Irvine, CA USA
[7] IQVIA Real World Evidence Solut, Cambridge, MA USA
[8] Univ Texas McGovern Med Sch, Houston, TX USA
[9] TIRR Mem Hermann, Houston, TX USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P640
引用
收藏
页码：321 / 322
页数：2
相关论文
共 50 条
  • [21] Real-World Effectiveness of Natalizumab in Korean Patients With Multiple Sclerosis
    Kim, Ki Hoon
    Kim, Su-Hyun
    Park, Na Young
    Hyun, Jae-Won
    Kim, Ho Jin
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [22] Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
    Milanov, Ivan
    Ivanova, Sonya
    Tournev, Ivailo
    Chamova, Teodora
    Kaprelyan, Ara
    Slavov, Georgi
    Chervenkov, Vitan
    Kipriyanovska, Katerina
    REVISTA DE NEUROLOGIA, 2023, 77 : S1 - S7
  • [23] Real-World Dosing Differences of OnabotulinumtoxinA and AbobotulinumtoxinA in Treatment of Upper Limb Spasticity
    Singh, Ritu
    Zuzek, Aleksej
    Schwartz, Marc
    Nelson, Mariana
    TOXICON, 2022, 214 : S69 - S70
  • [24] Safety and effectiveness of ocrelizumab in multiple sclerosis: a real-world study from spain
    Sempere, A.
    Berenguer-Ruiz, L.
    Burgos-San Jose, A.
    Aragones, M.
    Navarro-Lopez, M. D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 553 - 553
  • [25] OnabotulinumtoxinA Reduces Disability in Treatment-Naive Adult Patients with Spasticity: Results from the ASPIRE Study
    Jost, W.
    Ellenbogen, A.
    Wittenberg, G.
    Ngo, K.
    Largent, J.
    Zuzek, A.
    Francisco, G.
    Esquenazi, A.
    MOVEMENT DISORDERS, 2019, 34 : S561 - S561
  • [26] Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
    Ysrraelit, Maria Celica
    Caride, Alejandro
    Sinay, Vladimiro
    Rivera Kindel, Mario
    Halfon, Mario Javier
    Patrucco, Liliana
    Piedrabuena, Raul
    Diaz Aragunde, Vanina Eleonor
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (05) : 407 - 414
  • [27] OnabotulinumtoxinA treatment in adults with spasticity reduces caregiver burden: Results from the ASPIRE study
    Esquenazi, A.
    Ellenbogen, A.
    Wittenberg, G.
    Ngo, K.
    Largent, J.
    Zuzek, A.
    Francisco, G.
    Jost, W.
    MOVEMENT DISORDERS, 2019, 34 : S557 - S557
  • [28] Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Concomitant Treatment of Patients With Spasticity and Other Therapeutic Indications
    Mayadev, Angeli
    Ayyoub, Ziyad
    Patel, Atul
    Ifantides, Kim Becker
    Ukah, Ahunna
    Nelson, Mariana
    Battucci, Simona
    Brown, Theodore
    TOXICON, 2024, 237 : 58 - 59
  • [29] REAL-WORLD TREATMENT UTILIZATION AND SAFETY OF ONABOTULINUMTOXINA FOR CHRONIC MIGRAINE FROM AN OBSERVATIONAL STUDY IN THE EUROPEAN UNION
    Matharu, M.
    Pascual, J.
    Remahl, I. Nilsson
    Straube, A.
    Lum, A.
    Davar, G.
    Odom, D.
    Bennett, L.
    Proctor, C.
    Gutierrez, L.
    Andrews, E.
    Johannes, C.
    CEPHALALGIA, 2016, 36 : 27 - 27
  • [30] Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan
    Yang, Chih-Chao
    Ro, Long-Sun
    Tsai, Nai-Wen
    Lin, Chou-Ching
    Huang, Wen-Nan
    Tsai, Ching-Piao
    Lin, Thy-Sheng
    Su, Jen-Jen
    Huang, Chin-Chang
    Lyu, Rong-Kuo
    Chen, Hsin-Hua
    Lee, Wei-Ju
    Chen, Po-Lin
    Yang, Audrey
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 542 - 550
12345